PTC Therapeutics Inc
PTCT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.47B
Close$
$29.89
53.9% downside
Current Fair Value
53.9% downsideOvervalued by 53.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.47 Billion |
|---|---|
| Enterprise Value | $5.60 Billion |
| Earnings per Share | $8.58 |
| Beta | 0.51 |
| Outstanding Shares | 83,476,100 |
Return
| Return on Equity | 55.42% |
|---|---|
| Return on Assets | -3.30% |
| Return on Invested Capital | 4.72% |
Valuation & Multiples
| P/E Ratio | -49.95 |
|---|---|
| PEG | 11.75 |
| Price to Sales | 4.99 |
| Price to Book Ratio | -21.64 |
| Enterprise Value to Revenue | 4.84 |
| Enterprise Value to EBIT | 48.74 |
| Enterprise Value to Net Income | -53 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | -3.34 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS Estimate
$0.30
Consensus analyst estimateRevenue Estimate
$302.83 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 18, 2027
EPS Estimate
$0.35
Consensus analyst estimateRevenue Estimate
$330.38 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 15.32% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.98%▼ 112.10% |
|---|---|
| Total Invested | $536.62M▼ 93.51% |
| Investors Holding | 140▼ 254.00% |
About PTC Therapeutics Inc
CEO: Stuart Peltz
